“The greater the passive income you can build, the freer you will become”

Globally recognised

Since inception, Talaria has generated 7.45% p.a. in income for investors, including 7.49% in the 2021 financial year. As a result we are now one of the top global equity incomes funds in Australia and Europe.

See the comparative chart of Talaria Wholesale Funds 2020 income, versus the average from Europe and Australia – courtesy of Morningstar.

Income for lifestyle

From 2008 to 2021, almost all returns from the ASX200 came from dividends or reinvested dividends. Talaria’s investment process generates an additional and alternate source of income for investors. This income is not reliant on dividends, and for the last 10 years has generated on average over 9.0% per annum for investors.

See how this benefits investors in the video.

Globally leading

The Talaria Wholesale Fund has outperformed both the ASX200 and iShares MSCI World dividend yield indices over 1,3,5 and 7 year periods. In addition the fund generated nearly 10% income in 2021, from dividends, interest and option premiums. The slides to the right demonstrate this performance.

1 Source: Morningstar, 1/01/2020-31/12/2020 Global Equity Income (EU: EAA OE Global Equity Income & Aust: Talaria Global Equity Hedged,   Epoch Global Equity Shareholder Yield Fund Unhedged, Talaria Global Equity, Janus Henderson Global Equity Income Fund, Plato Global Shares Income Fund, Wheelhouse Global Equity Income) Currency: Base Currency
2 Distributions for the Talaria Global Equity Fund, Wholesale Units, year ending 30 June 2021. Returns are calculated after fees and expenses and assume the reinvestment of distributions.
3 Sources: Bloomberg, FactSet, Talaria. Talaria Global Equity Fund distribution calculations based on the distributions paid in each financial year, using financial year starting values to determine annual distribution yield to December2020S&P/ASX200 and iShares World (ex Aus) Index (URTH) DividendYields = 12mth DY. Numbers may not sum due to geometric compounding and rounding. Past performance is not an indicator of future performance.

4 Source: Talaria, as at 31 December 2021. Option premium generated is on capital account and is therefore not always distributable.

Important Information
Units in the Talaria Global Equity Fund (Managed Fund) (the Fund) and the Talaria Global Equity Fund – Currency Hedged (Managed Fund) are issued by Australian Unity Funds Management Limited ABN 60 071 497 115, AFS Licence No. 234454. The information in this document is general information only and is not based on the financial objectives, situation or needs of any particular investor. In deciding whether to acquire, hold or dispose of the product you should obtain a copy of the current Product Disclosure Statement (PDS) for the Wholesale Units and consider whether the product is appropriate for you. A copy of the PDS for Wholesale Units is available at australianunity.com.au/wealth or by calling the Adviser Support team on 1800 649 033. Investment decisions should not be made upon the basis of the Fund’s past performance or distribution rate, or any ratings given by a rating agency, since each of these can vary. In addition, ratings need to be understood in the context of the full report issued by the rating agency itself. The information provided in the document is current at the time of publication.

The information transmitted is intended only for the person or entity to which it is addressed and may contain confidential and/or privileged material. Any review, retransmission, dissemination or other use of, or taking of any action in reliance upon, this information by persons or entities other than the intended recipient is prohibited. If you received this in error, please contact the sender and permanently delete the material from your computer system. We cannot guarantee that this e-mail is virus-free. You should scan attachments with the latest virus scan before opening. We will not be liable for any loss, cost or damage of any kind whatsoever caused by any receipt or use of this e-mail and attachments.

The rating issued 04/2022 is published by Lonsec Research Pty Ltd ABN 11 151 658 561 AFSL 421 445 (Lonsec). Ratings are general advice only, and have been prepared without taking account of your objectives, financial situation or needs. Consider your personal circumstances, read the product disclosure statement and seek independent financial advice before investing. The rating is not a recommendation to purchase, sell or hold any product. Past performance information is not indicative of future performance. Ratings are subject to change without notice and Lonsec assumes no obligation to update. Lonsec uses objective criteria and receives a fee from the Fund Manager. Visit lonsec.com.au for ratings information and to access the full report. © 2022 Lonsec. All rights reserved.

The Zenith Investment Partners (ABN 27 103 132 672, AFS Licence 226872) (“Zenith”) rating (assigned (assigned November 24, 2021 for funds AUS0035AU and WFS0547AU) referred to in this piece is limited to “General Advice” (s766B Corporations Act 2001) for Wholesale clients only. This advice has been prepared without taking into account the objectives, financial situation or needs of any individual, including target markets of financial products, where applicable, and is subject to change at any time without prior notice. It is not a specific recommendation to purchase, sell or hold the relevant product(s). Investors should seek independent financial advice before making an investment decision and should consider the appropriateness of this advice in light of their own objectives, financial situation and needs. Investors should obtain a copy of, and consider the PDS or offer document before making any decision and refer to the full Zenith Product Assessment available on the Zenith website. Past performance is not an indication of future performance. Zenith usually charges the product issuer, fund manager or related party to conduct Product Assessments. Full details regarding Zenith’s methodology, ratings definitions and regulatory compliance are available on our Product Assessments and at Fund Research Regulatory Guidelines.